|
Volumn 22, Issue 1, 2002, Pages 370-377
|
p19ARF is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
PROTEIN P19;
PROTEIN P53;
RNA;
ANIMAL MODEL;
APOPTOSIS;
ARTICLE;
BRAIN TUMOR;
CELL CYCLE;
CELL SPECIFICITY;
CELL TYPE;
IN SITU HYBRIDIZATION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
TRANSGENIC MOUSE;
TUMOR GROWTH;
TUMOR SUPPRESSOR GENE;
ANIMALS;
APOPTOSIS;
CELL CYCLE PROTEINS;
CELL DIVISION;
CHOROID PLEXUS;
CHOROID PLEXUS NEOPLASMS;
CYCLIN-DEPENDENT KINASE INHIBITOR P16;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
DISEASE MODELS, ANIMAL;
DNA-BINDING PROTEINS;
E2F TRANSCRIPTION FACTORS;
E2F1 TRANSCRIPTION FACTOR;
ENZYME INHIBITORS;
EPITHELIAL CELLS;
GENES, P16;
HUMANS;
IN SITU HYBRIDIZATION;
IN SITU NICK-END LABELING;
MICE;
MICE, TRANSGENIC;
NUCLEAR PROTEINS;
ONCOGENE PROTEINS, VIRAL;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-MDM2;
SIGNAL TRANSDUCTION;
TRANSCRIPTION FACTORS;
TUMOR SUPPRESSOR PROTEIN P14ARF;
TUMOR SUPPRESSOR PROTEIN P53;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 0036133649
PISSN: 02707306
EISSN: None
Source Type: Journal
DOI: 10.1128/MCB.22.1.370-377.2002 Document Type: Article |
Times cited : (78)
|
References (35)
|